Roivant Sciences (NASDAQ:ROIV – Get Free Report) is expected to announce its Q1 2027 results before the market opens on Thursday, August 6th. Roivant Sciences Stock Down 2.9%Shares of ROIV stock opened at $32.87 on Thursday. Roivant Sciences has a 52 week low of $10.90 and a 52 week high of $37.00. Roivant Sciences Company Profile(Get Free Report)Roivant Sciences is a biopharmaceutical company focused on the development and commercialization of innovative therapies through a network of subsidiary businesses known as “Vants.” Read MoreReceive News & Ratings for Roivant Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roivant Sciences and related companies with MarketBeat.com's FREE daily email newsletter.